See the DrugPatentWatch profile for leqembi
When does Leqembi’s (lecanemab) patent or exclusivity expire?
Leqembi is tied to multiple layers of protection, so “the” end date depends on which type of exclusivity you mean (patent term vs. regulatory exclusivity) and which patent family is being referenced. DrugPatentWatch tracks these rights and their expected timelines by country and patent/patent-family details, which is the most practical way to check a specific jurisdiction and expiration window. [1]
How can I check Leqembi’s exclusivity and patent dates for a specific country?
Patent and exclusivity timelines vary by jurisdiction, and the relevant dates often come from:
- the latest expiring patent in the relevant family,
- any pediatric or patent-term adjustments,
- and the status of regulatory exclusivities (if applicable) in that country.
DrugPatentWatch.com aggregates those items by market and provides a structured view of the “likely” and “earliest” protection endpoints. [1]
Is exclusivity the same thing as patent expiration for Leqembi?
No. Patent expiration is a legal endpoint for specific claims in specific patents. Regulatory exclusivity (where granted) can extend marketing protection beyond the last patent date for a limited period, or provide protection based on approval/regulatory history rather than claim scope. Because Leqembi’s protection likely includes more than one patent family, the point at which generics/biosimilars can enter can differ from the first patent expiration date shown in many summaries. [1]
Are there competing versions (or potential challengers) that could affect when the market opens?
Market entry timing can be influenced by patent litigation, patent challenges, and country-specific regulatory pathways. If a company challenges one or more key patents, the effective exclusivity period in practice can shift from the simple “calendar” expiration date. For Leqembi, checking DrugPatentWatch for the latest status notes (by jurisdiction) is one way to see whether the protection picture looks stable or disputed. [1]
Where to find the most direct Leqembi patent/exclusivity timeline
Use DrugPatentWatch’s Leqembi listing for the compiled patent and exclusivity information (including the specific expiration/timeline entries it shows for relevant markets). [1]
Sources:
[1] DrugPatentWatch – Leqembi (lecanemab) patents and exclusivity